Toshihiko Okazaki

2.6k citations

26 papers · 1.9k indexed · 1 hit paper · h-index 14

Immunology top 2%
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Mast cells and histamine 2
Gastroenterology top 2%
Cancer Research top 10%
Oncology top 10%
- CAR-T cell therapy research 2
Genetics top 5%
- Virus-based gene therapy research 4
- Inflammatory Bowel Disease 4
Surgery
- Helicobacter pylori-related gastroenterology studies 3
Epidemiology
- Virology and Viral Diseases 2

Co-authors: Osamu Takeuchi Shizuo Akira Takashi Satoh Koubun Yasuda Kiri Honma Kazufumi Matsushita Toru Miyake Katsuyuki Yui
Cited by: Immunology Gastroenterology Cancer Research
Partner nations: Japan United States Canada

In The Last Decade

Toshihiko Okazaki

26 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection

Peers

Countries citing papers authored by Toshihiko Okazaki

Since Specialization

Citations

This map shows the geographic impact of Toshihiko Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Okazaki more than expected).

Fields of papers citing papers by Toshihiko Okazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Okazaki. The network helps show where Toshihiko Okazaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toshihiko Okazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshihiko Okazaki Line = papers co-authored together Toshihiko Okazaki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors Yasuki Hijikata,Toshihiko Okazaki,Yoshihiro Tanaka,Mutsunori Murahashi,Yuichi Yamada,Kazunari Yamada,Atsushi Takahashi,Hiroyuki Inoue,Junji Kishimoto,Yoichi Nakanishi,Yoshinao Oda,Yusuke Nakamura,Kenzaburo Tani	2018	14
2	Investigator initiated clinical trial of cancer vaccine OCV-C01 in advanced and recurrent biliary tract cancer Mutsunori Murahashi,Hisanobu Ogata,Toshihiko Okazaki,Yasuki Hijikata,Kazunari Yamada,Toshihisa Tsuruta,Junji Kishimoto,Kouta Funakoshi,Koji Todaka,Yoichi Nakanishi,Kenzaburo Tani	2018	1
3	A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11 Beibei Wang,Hisanobu Ogata,Yuto Takishima,Shohei Miyamoto,Hiroyuki Inoue,Masaki Kuroda,Kazunari Yamada,Yasuki Hijikata,Mutsunori Murahashi,Hiroyuki Shimizu,Toshihiko Okazaki,Yoichi Nakanishi,Kenzaburo Tani	2018	13
4	A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity Kaname Nosaki,Katsuyuki Hamada,Yuto Takashima,Miyako Sagara,Yumiko Matsumura,Shohei Miyamoto,Yasuki Hijikata,Toshihiko Okazaki,Yoichi Nakanishi,Kenzaburo Tani	2016	35
5	TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells Megumi Narusawa,Hiroyuki Inoue,Chika Sakamoto,Yumiko Matsumura,Atsushi Takahashi,Tomoko Inoue,Ayumi Watanabe,Shohei Miyamoto,Yoshie Miura,Yasuki Hijikata,Yoshihiro Tanaka,Makoto Inoue,Koichi Takayama,Toshihiko Okazaki,Mamoru Hasegawa,Yoichi Nakanishi,Kenzaburo Tani	2014	15
6	Protection of tobacco cells from oxidative copper toxicity by catalytically active metal-binding DNA oligomers Junichiro Iwase,Hiroka Furukawa,Takuya Hiramatsu,François Bouteau,Stefano Mancuso,Ken‐ichiro Tanaka,Toshihiko Okazaki,Tomonori Kawano	2014	11
7	Critical Role of AZI2 in GM-CSF–Induced Dendritic Cell Differentiation Masahiro Fukasaka,Daisuke Ori,Tatsukata Kawagoe,Satoshi Uematsu,Kenta Maruyama,Toshihiko Okazaki,Tatsuya Kozaki,Tomoko Imamura,Sarang Tartey,Takashi Mino,Takashi Satoh,Shizuo Akira,Osamu Takeuchi	2013	19
8	Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma Shohei Miyamoto,Hiroyuki Inoue,Takafumi Nakamura,Meiko Yamada,Chika Sakamoto,Yasuo Urata,Toshihiko Okazaki,Tomotoshi Marumoto,Atsushi Takahashi,Koichi Takayama,Yoichi Nakanishi,Hiroyuki Shimizu,Kenzaburo Tani	2012	188
9	6‐mercaptopurine transport in human lymphocytes: Correlation with drug‐induced cytotoxicity Laurie S. Conklin,Carmen Cuffari,Toshihiko Okazaki,Yinglei Miao,Bahman Saatian,Tiane Chen,Ming Tse,Steven R. Brant,Xuhang Li	2011	8
10	Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma Xin Meng,Takafumi Nakamura,Toshihiko Okazaki,Hiroyuki Inoue,Atsushi Takahashi,Shohei Miyamoto,Gaku Sakaguchi,Masatoshi Eto,Seiji Naito,Makoto Takeda,Yusuke Yanagi,Kenzaburo Tani	2010	30
11	The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infectionbreakdown → Takashi Satoh,Osamu Takeuchi,Alexis Vandenbon,Koubun Yasuda,Yoshiaki Tanaka,Yutaro Kumagai,Toru Miyake,Kazufumi Matsushita,Toshihiko Okazaki,Tatsuya Saitoh,Kiri Honma,T. Matsuyama,Katsuyuki Yui,Tohru Tsujimura,Daron M Standley,Kenji Nakanishi,Kenta Nakai,Shizuo Akira	2010	926
12	Construction of a high-performance human fetal liver-derived lentiviral cDNA library Ryo Kurita,Tatsuo Oikawa,Michiyo Okada,Tomoko Yokoo,Yuusuke Kurihara,Yuko Honda,Rui Kageyama,Youko Suehiro,Toshihiko Okazaki,Mutsunori Iga,Hiroyuki Miyoshi,Kenzaburo Tani	2008	6
13	Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohnʼs disease risk in a population-based case-control study: Evidence of gene–gene interactions Toshihiko Okazaki,Ming‐Hsi Wang,Patricia Rawsthorne,Michael Sargent,Lisa W. Datta,Yin Yao Shugart,Çharles N. Bernstein,Steven R. Brant	2008	57
14	Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system Toshihiko Okazaki,Daitoku Sakamuro	2007	7
15	NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives Joon‐Young Park,Iain K. Farrance,Nicola M. Fenty,James M. Hagberg,Stephen M. Roth,David M. Mosser,Min Qi Wang,Hanjoong Jo,Toshihiko Okazaki,Steven R. Brant,Michael D. Brown	2007	34
16	A novel NFKB1 promoter polymorphism shows altered binding to nuclear proteins and increases risk for ulcerative colitis Steven R. Brant,Amir Karban,Toshihiko Okazaki,Carolien Panhuysen,Thomas F. Gallegos,James J. Potter,Richard H. Duerr,Mark S. Silverberg,Judy H. Cho,Peter K. Gregersen,Yuquiong Wu,Esteban Mezey,Themistocles Dassopoulos,Joan E. Bailey Wilson,Theodore M. Bayless,Franklin J. Nouvet	2003	1
17	Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis Amir Karban,Toshihiko Okazaki,Carolien Panhuysen,Thomas F. Gallegos,James J. Potter,Joan E. Bailey‐Wilson,Mark S. Silverberg,Richard H. Duerr,Judy H. Cho,Peter K. Gregersen,Yuqiong Wu,Jean-Paul Achkar,Themistocles Dassopoulos,Esteban Mezey,Theodore M. Bayless,Franklin J. Nouvet,Steven R. Brant	2003	289
18	Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours Seiichi Hirota,Toshirou Nishida,Koji Isozaki,Masahiko Taniguchi,Junichi Nakamura,Toshihiko Okazaki,Yukihiko Kitamura	2001	178
19	The non-invasive functional tissue characterization for arteriosclerosis by artery wall motion analysis with time series high-speed echo images and continuous sphygmomanometer Toshiaki Nagakura,Koji Masuda,Yosuke Ooe,Shinya Kosuge,Shinya Kosuge,Y. Hase,Toshihiko Okazaki,Ken Ishihara,Masatsugu Hori,Toshiyuki Furukawa	2001	1
20	[Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors]. Y Yanagawa,Toshihiko Okazaki,Seisuke Okamura,M Ueki,Osamu Sugimoto	1989	2

About Toshihiko Okazaki

Toshihiko Okazaki is a scholar working on Immunology, Gastroenterology and Genetics, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Inflammatory Bowel Disease (4 papers), Immunotherapy and Immune Responses (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Virology and Viral Diseases (2 papers), CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Immunology (930 citations), Gastroenterology (188 citations) and Cancer Research (264 citations). Toshihiko Okazaki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Osamu Takeuchi, Shizuo Akira, Takashi Satoh, Koubun Yasuda, Kiri Honma, Kazufumi Matsushita, Toru Miyake, Katsuyuki Yui, Tatsuya Saitoh and Kenji Nakanishi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact